Search

everythinglearnresearchcommunity

for

Search:↓

PLD is an effective and safer alternative for treating breast cancer.

Advanced imaging techniques are crucial for accurately diagnosing Monilethrix, a rare hair disorder.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

The MPV/PC ratio can help assess disease activity in alopecia areata.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The study found that it's hard to tell the difference between two types of hair loss, alopecia areata and telogen effluvium, by looking at symptoms and tissue samples.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Minoxidil can be effectively encapsulated in coated nanovesicles for potential drug delivery.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

The case shows the importance of quick and thorough evaluation of adrenal tumors to prevent rapid disease progression and poor outcomes.

Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Aging skin shows thinner layers, fewer hair follicles, and new biomarkers like increased space between cells and smaller sebaceous glands.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Allergens show specific patterns related to season, gender, and age, which can help in developing allergy avoidance plans.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Hair follicle pores help cell survival and growth, even after radiation.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.